Tracing hepatitis C and Delta viruses to estimate their contribution in HCC rates in Mongolia

Journal of Viral Hepatitis

Volumn 14, Issue 9, 2007, Pages 667-674

  Kurbanov, F ^a   Tanaka, Y ^a   Elkady, A ^a   Oyunsuren, T ^b   Mizokami, M ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b INSTITUTE OF CHEMISTRY AND CHEMICAL TECHNOLOGY   (Mongolia)

Author keywords

Coalescence theory; Hepatitis C virus; Hepatitis Delta virus; Hepatocellular carcinoma; Molecular epidemiology; Mongolia

Indexed keywords

ARTICLE; CANCER RISK; COMORBIDITY; DISEASE ASSOCIATION; EPIDEMIC; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS DELTA VIRUS; HUMAN; LIVER CELL CARCINOMA; MONGOLIA; POPULATION GENETICS; PRIORITY JOURNAL; SEROPREVALENCE; VIRUS DETECTION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; DISEASE OUTBREAKS; FEMALE; HEPACIVIRUS; HEPATITIS B; HEPATITIS C; HEPATITIS D; HEPATITIS DELTA VIRUS; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MONGOLIA; PHYLOGENY;

EID: 34547917958     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2007.00864.x     Document Type: Article

References (37)

1. Bosch FX, Ribes J, Diaz M, Cleries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004 127 (5 Suppl. 1 S5 S16.
2. Dulamsuren S. Report of the Ministry of Health, Mongolia. Health Indicators 2004 58 : 34 p.
3. Kondo Y, Mizokami M, Nakano T et al. Prevalence and molecular epidemiology of GB virus C/hepatitis G virus infection in Mongolia. J Med Virol 1997 52 : 143 148.
4. Tsatsralt-Od B, Takahashi M, Nishizawa T, Inoue J, Ulaankhuu D, Okamoto H. High prevalence of hepatitis B, C and delta virus infections among blood donors in Mongolia. Arch Virol 2005 150 : 2513 2528.
5. Inoue J, Takahashi M, Nishizawa T et al. High prevalence of hepatitis delta virus infection detectable by enzyme immunoassay among apparently healthy individuals in Mongolia. J Med Virol 2005 76 : 333 340.
6. Oyunsuren T, Kurbanov F, Tanaka Y et al. High frequency of hepatocellular carcinoma in Mongolia: association with mono-, or co-infection with hepatitis C, B and Delta viruses. J Med Virol 2006 78 (12 1688 1695.
7. Tsatsralt-Od B, Takahashi M, Nishizawa T, Endo K, Inoue J, Okamoto H. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia. J Med Virol 2005 77 : 491 499.
8. Pybus OG, Charleston MA, Gupta S, Rambaut A, Holmes EC, Harvey PH. The epidemic behavior of the hepatitis C virus. Science 2001 292 : 2323 2325.
9. Pybus OG, Rambaut A. GENIE: estimating demographic history from molecular phylogenies. Bioinformatics 2002 18 : 1404 1405.
10. Tanaka Y, Hanada K, Mizokami M et al. A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades. Proc Natl Acad Sci USA 2002 99 : 15584 15589.
11. Tanaka Y, Agha S, Saudy N et al. Exponential spread of hepatitis C virus genotype 4a in Egypt. J Mol Evol 2004 58 : 191 195.
12. Mizokami M, Tanaka Y. Tracing the evolution of hepatitis C virus in the United States, Japan, and Egypt by using the molecular clock. Clin Gastroenterol Hepatol 2005 3 (10 Suppl. 2 S82 S85.
13. Tanaka Y, Kurbanov F, Mano S et al. Molecular tracing of the global hepatitis C virus epidemic predicts regional patterns of hepatocellular carcinoma mortality. Gastroenterology 2006 130 : 703 714.
14. Strimmer K, Pybus OG. Exploring the demographic history of DNA sequences using the generalized skyline plot. Mol Biol Evol 2001 18 : 2298 2305.
15. Kurbanov F, Kondo M, Tanaka Y et al. Human immunodeficiency virus in Uzbekistan: epidemiological and genetic analyses. AIDS Res Hum Retroviruses 2003 19 : 731 738.
16. Salemi M, de Oliveira T, Soares MA et al. Different epidemic potentials of the HIV-1B and C subtypes. J Mol Evol 2005 60 : 598 605.
17. Carrington CV, Foster JE, Pybus OG, Bennett SN, Holmes EC. Invasion and maintenance of dengue virus type 2 and type 4 in the Americas. J Virol 2005 79 : 14680 14687.
18. Michitaka K, Tanaka Y, Horiike N et al. Tracing the history of hepatitis B virus genotype D in western Japan. J Med Virol 2006 78 : 44 52.
19. Ohno T, Mizokami M, Wu RR et al. New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a. J Clin Microbiol 1997 35 : 201 207.
20. Nakano T, Shapiro CN, Hadler SC et al. Characterization of hepatitis D virus genotype III among Yucpa Indians in Venezuela. J Gen Virol 2001 82 (Pt 9 2183 2189.
21. Kuiken C, Mizokami M, Deleage G et al. Hepatitis C databases, principles and utility to researchers. Hepatology 2006 43 : 1157 1165.
22. Zhang YY, Hansson BG. Introduction of a new hepatitis agent in retrospect: genetic studies of Swedish hepatitis D virus strains. J Clin Microbiol 1996 34 : 2713 2717.
23. Lee CM, Bih FY, Chao YC, Govindarajan S, Lai MM. Evolution of hepatitis delta virus RNA during chronic infection. Virology 1992 188 : 265 273.
24. Chao YC, Tang HS, Hsu CT. Evolution rate of hepatitis delta virus RNA isolated in Taiwan. J Med Virol 1994 43 : 397 403.
25. Rizzetto M, Canese MG, Gerin JL, London WT, Sly DL, Purcell RH. Transmission of the hepatitis B virus-associated delta antigen to chimpanzees. J Infect Dis 1980 141 : 590 602.
26. Tsatsralt-Od B, Takahashi M, Endo K et al. Infection with hepatitis A, B, C, and delta viruses among patients with acute hepatitis in Mongolia. J Med Virol 2006 78 : 542 550.
27. Mizokami M, Orito E, Ohba K, Ikeo K, Lau JY, Gojobori T. Constrained evolution with respect to gene overlap of hepatitis B virus. J Mol Evol 1997 44 (Suppl. 1 S83 S90.
28. Hannoun C, Horal P, Lindh M. Long-term mutation rates in the hepatitis B virus genome. J Gen Virol 2000 81 (Pt 1 75 83.
29. Morozov V, Pisareva M, Groudinin M. Homologous recombination between different genotypes of hepatitis B virus. Gene 2000 260 : 55 65.
30. Simmonds P, Midgley S. Recombination in the genesis and evolution of hepatitis B virus genotypes. J Virol 2005 79 : 15467 15476.
31. Dandii D, Jamba G, Nyamdawa P. Mongolia is the first Asian country annihilated smallpox. Symposium 'Current issues of Biotechnology and Molecular Biology' dedicated to 70 years of start to produce Medical bioproducts in Mongolia. 2003 Conference Abstracts: 29-32.
32. Aslam M, Aslam J, Mitchell BD, Munir KM. Association between smallpox vaccination and hepatitis C antibody positive serology in Pakistani volunteers. J Clin Gastroenterol 2005 39 : 243 246.
33. Kurbanov F, Tanaka Y, Sugauchi F et al. Hepatitis C virus molecular epidemiology in Uzbekistan. J Med Virol 2003 69 : 367 375.
34. Takahashi M, Nishizawa T, Gotanda Y et al. High prevalence of antibodies to hepatitis A and E viruses and viremia of hepatitis B, C, and D viruses among apparently healthy populations in Mongolia. Clin Diagn Lab Immunol 2004 11 : 392 398.
35. Davaalkham D, Ojima T, Nymadawa P et al. Prevalence and risk factors for hepatitis C virus infection in Mongolian children: findings from a nationwide survey. J Med Virol 2006 78 : 466 472.
36. Tanaka Y, Hanada K, Orito E et al. Molecular evolutionary analyses implicate injection treatment for schistosomiasis in the initial hepatitis C epidemics in Japan. J Hepatol 2005 42 : 47 53.
37. Lu L, Nakano T, He Y, Fu Y, Hagedorn CH, Robertson BH. Hepatitis C virus genotype distribution in China: predominance of closely related subtype 1b isolates and existence of new genotype 6 variants. J Med Virol 2005 75 : 538 549.